Buprenorphine And Naloxone Film
Product Images NDC 67296-2228

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Buprenorphine And Naloxone (NDC 67296-2228). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Redpharm Drug, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Ctn12mg (Ctn12mg)

Ctn12mg (Ctn12mg)
This text appears to be information about a medication called Buprenorphine and Naloxone Sublingual Film. It mentions the importance of keeping the medication out of reach of children and not cutting, chewing, or swallowing the film. The medication is intended for prescription use, and each pouch contains one sublingual film. It also provides instructions for administering the medication orally and advises on proper storage conditions. It is essential to follow the guidelines provided and seek emergency medical care if the medication is accidentally ingested by a child.*
FDA Label Image

Ctn2mg (Ctn2mg)

Ctn2mg (Ctn2mg)
This text is a description of a medication called Buprenorphine and Naloxone Sublingual Film intended for emergency medical care in cases of accidental ingestion by children. The instructions advise keeping the medication out of reach of children, not cutting, chewing, or swallowing the film, and dispensing a Medication Guide to each patient. Each pouch contains 1 sublingual film. The film contains 2.1 mg of naloxone hydrochloride and 8 mg of buprenorphine hydrochloride, equivalent to 1.005 g of substance. Additional information outlines dosing instructions and precautions.*
FDA Label Image

Ctn4mg (Ctn4mg)

Ctn4mg (Ctn4mg)
This is a medicine label for Buprenorphine and Naloxone Sublingual Film, which is used for opioid dependency treatment. The label includes dosage information, instructions for use, emergency contact details, storage recommendations, and a warning to keep the medication out of reach of children. It is important not to chew, swallow, or cut the sublingual film. The medication guide should be dispensed with each prescription.*
FDA Label Image

Ctn8mg (Ctn8mg)

Ctn8mg (Ctn8mg)
This is information about a medication called Buprenorphine and Naloxone sublingual film, which contains 8 mg of buprenorphine and 2 mg of naloxone per film. It is important to keep it away from children as accidental ingestion may require emergency medical care. The pharmacist should dispense a Medication Guide to each patient. The instructions specify not to cut, chew, or swallow the film, and provide guidance on administration under the tongue or inside the cheek. The medication should be stored at controlled room temperature. Each pouch contains one sublingual film, and there are a total of 30 pouches in a box.*
FDA Label Image

Figure3.jpg (Figue3)

FDA Label Image

Figure1.jpg (Figure1)

FDA Label Image

Figure2.jpg (Figure2)

FDA Label Image

Figure4.jpg (Figure4)

FDA Label Image

Structurebuprenorpine.jpg (Structurebuprenorpine)

FDA Label Image

Structurenaloxone.jpg (Structurenaloxone)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.